ORENCIA (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the ORENCIA drug offered from E.R. Squibb & Sons, L.L.C.. This Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | abatacept |
| SUBSTANCE NAME: | ABATACEPT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-01-01 |
| END MARKETING DATE: | 0000-00-00 |
ORENCIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ORENCIA from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/15mL) |
| START MARKETING DATE: | 2009-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-2187_5ada8930-df4f-4371-9229-c66142f2c249 |
| PRODUCT NDC: | 0003-2187 |
| APPLICATION NUMBER: | BLA125118 |
Other ABATACEPT Pharmaceutical Manufacturers / Labelers:
